Live Breaking News & Updates on National Key Rd Programmes|Page 6
Stay updated with breaking news from National key rd programmes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
E-Mail IMAGE: Sumit Chanda, co-senior study author and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys. view more Credit: Sanford Burnham Prebys Medical Discovery Institute LA JOLLA, CALIF. - March 16, 2021 - A Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization s List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2 and prevents the exaggerated inflammatory response associated with severe COVID-19. Based on these findings, a Phase 2 study evaluating clofazimine as an at-home treatment for COVID-19 could begin immediately. ....